Feed RDHL
RD
RedHill Biopharma Ltd.
RDHL · NASDAQ
$0.59 -1.51% (-$0.01)
1M -15.30%
Market Cap $1.84M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.81
36.6% upside
Preț actual
$0.59
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile RDHL sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.19x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 83.34%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 97.52%
Op. margin 110.40%
FCF margin 85.98%
Quality
66 /100
Average ROA 50.68%
Asset turnover 0.52x
ROIC 285.10%
Debt
4 /100
High Int. coverage -7.99x
Current ratio 0.56x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Rev. volatility 67.13%
EPS volatility 126.53%
Profitable years 0
Întreabă StockBot despre RDHL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dror Ben-Asher
Employees
13
Headquarters
Tel Aviv
Evenimente viitoare
20 AUG.
Earnings
Upcoming earnings report